ArticleOncotarget2018

20(S)-protopanaxadiol regio-selectively targets androgen receptor: anticancer effects in castration-resistant prostate tumors.

Mohamed Ben-Eltriki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.